Search research articles
Contact Us
Filters
Showing results (21-30 of 26) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 26 results.
Cardiovascular Diabetology
|
August 6, 2022
Evolocumab on top of empagliflozin improves endothelial function of individuals with diabetes: randomized active-controlled trial
Andrei C Sposito, Ikaro Breder, Joaquim Barreto, et al.
Current Medical Research and Opinion
|
February 17, 2022
Rationale and design of the Brazilian diabetes study: a prospective cohort of type 2 diabetes
Joaquim Barreto, Vaneza Wolf, Isabella Bonilha, et al.
Molecular Genetics and Metabolism
|
March 8, 2023
Phenotypic changes in low-density lipoprotein particles as markers of adverse clinical outcomes in COVID-19
Helison Rafael P Carmo, Marcos Y Yoshinaga, Alejandro Rosell Castillo, et al.
Diabetology & Metabolic Syndrome
|
August 7, 2019
Assessment of dapagliflozin effect on diabetic endothelial dysfunction of brachial artery (ADDENDA-BHS2 trial): rationale, design, and baseline characteristics of a randomized controlled trial
Riobaldo M R Cintra, Alexandre A S Soares, Ikaro Breder, et al.
Frontiers in Pharmacology
|
October 22, 2024
Diacerein reduces inflammasome activation and SARS-CoV-2 virus replication: a proof-of-concept translational study
Helison R P Carmo, Alejandro Rossel Castillo, Isabella Bonilha, et al.
Immunology
|
April 23, 2025
Obesity-Induced Metabolic Priming Exacerbates SARS-CoV-2 Inflammation
Gustavo Gastão Davanzo, Bianca Gazieri Castelucci, Gabriela Fabiano de Souza, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 26) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 26 results.
Cardiovascular Diabetology
|
August 6, 2022
Evolocumab on top of empagliflozin improves endothelial function of individuals with diabetes: randomized active-controlled trial
Andrei C Sposito, Ikaro Breder, Joaquim Barreto, et al.
Current Medical Research and Opinion
|
February 17, 2022
Rationale and design of the Brazilian diabetes study: a prospective cohort of type 2 diabetes
Joaquim Barreto, Vaneza Wolf, Isabella Bonilha, et al.
Molecular Genetics and Metabolism
|
March 8, 2023
Phenotypic changes in low-density lipoprotein particles as markers of adverse clinical outcomes in COVID-19
Helison Rafael P Carmo, Marcos Y Yoshinaga, Alejandro Rosell Castillo, et al.
Diabetology & Metabolic Syndrome
|
August 7, 2019
Assessment of dapagliflozin effect on diabetic endothelial dysfunction of brachial artery (ADDENDA-BHS2 trial): rationale, design, and baseline characteristics of a randomized controlled trial
Riobaldo M R Cintra, Alexandre A S Soares, Ikaro Breder, et al.
Frontiers in Pharmacology
|
October 22, 2024
Diacerein reduces inflammasome activation and SARS-CoV-2 virus replication: a proof-of-concept translational study
Helison R P Carmo, Alejandro Rossel Castillo, Isabella Bonilha, et al.
Immunology
|
April 23, 2025
Obesity-Induced Metabolic Priming Exacerbates SARS-CoV-2 Inflammation
Gustavo Gastão Davanzo, Bianca Gazieri Castelucci, Gabriela Fabiano de Souza, et al.
Page
of 3